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ABSTRACT 
The accurate and cost effective identification of left ventricular (LV) hypertrophy is clinically relevant due 
to its association with cardiac mortality in the general population. PURPOSE: To determine if 
electrocardiographic (ECG) voltage criteria predicts LV mass measured with cardiac ultrasound in 
collegiate American-style football (ASF) players. METHODS: Over a 3-year period, standard resting, 
supine 12-lead ECG and echocardiographic (ECHO) procedures were performed on 76 collegiate ASF 
players first entering an NCAA Football Bowl Subdivision university as part of their preparticipation 
physical exams. Player demographics were: age=18±1 yr., height=186±7 cm, weight=100.1±22.0 kg, 
BMI=28.6±5.0 kg·m2, and BSA=2.24±0.25 m2. Linear regression was used to predict ECHO-derived LV 
mass and LV mass/BSA index from ECG precordial-lead voltage criteria [sum largest S (V1 or V2) + R (V5 
or V6) ≥ 35 mm]. RESULTS: ECG voltage criteria did not significantly (p > 0.05) predict ECHO LV mass 
(LV mass = -0.12x + 216.94, r = 0.024, R² = 0.0006), or LV mass/BSA index (LV mass/BSA = 0.3063x + 
81.951, r = 0.17, R² = 0.0244). CONCLUSION: ECG precordial lead voltage was not clinically useful in 
diagnosing ECHO-derived LV hypertrophy in our sample of first-year collegiate ASF players. We suggest 
that new and more accurate algorithms for evaluating LV hypertrophy in ASF athletes be explored, 
possibly using demographic, body habitus, cardiovascular, and other ECG criteria. 
 
  
 
 
 
 
  
